Abstract
The overactive bladder (OAB) can be diagnosed clinically. The cornerstone symptom is urgency and the presence of other urinary symptoms or signs can guide the differential diagnosis using adjunctive instrumental test. The flowchart includes history, clinical examination, urine culture and urine analysis, voiding diaries and symptom questionnaires scores. Urodynamic examination is not a first-line test, but it should be done in case of complicated OAB.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brubaker L, Chapple C, Coyne KS, Kopp Z. Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment. Urology. 2006;68(suppl 2):3–8.
Haylen BT, de Ridder D. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4–20.
Starkman JS, Dmochowski RR. Urgency assessment in the evaluation of overactive bladder (OAB). Neurourol Urodyn. 2008;27(1):13–21.
Burgio KL, Engel BT, Locher JL. Normative patterns of diurnal urination across six age decades. J Urol. 1991;145:728.
Van Haarst E, Heldeweg E, Newling D, et al. The 24-h frequency-volume chart in adults reporting no voiding complaints: defining reference values and analysing variables. BJU Int. 2004;93:1257.
Miller JM, Garcia CE, Hortsch SB. Does instruction to eliminate coffee, tea, alcohol, carbonated, and artificially sweetened beverages improve lower urinary tract symptoms? A prospective trial. Wound Ostomy Continence Nurs. 2016;43(1):69–79.
Irwin DE, Abrams P, et al. Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int. 2008;101(11):1381–7.
Irwin DE, Milsom I, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–15.
Irwin DE, Milsom I, et al. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol. 2009;56(1):14–20.
Wein A. Symptom-based diagnosis of overactive bladder: an overview. Can Urol Assoc J. 2011;5(5 Suppl 2):S135–6.
Mongiu AK, McVary KT. Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity. Curr Prostate Rep. 2009;7:63–9.
Nik-Ahd F, Lenore Ackerman A, Anger J. Recurrent urinary tract infections in females and the overlap with overactive bladder. Curr Urol Rep. 2018;19(11):94.
Arinzon Z, et al. Clinical presentation of urinary tract infection (UTI) differs with aging in women. Arch Gerontol Geriatr. 2012;55:145.
Moore EE, et al. Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol. 2008;111:317.
Propert KJ, Schaeffer AJ, Brensinger CM, et al. A prospective study of interstitial cystitis: results of longitudinal follow up of them interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group. J Urol. 2000;163(5):1434–9.
Ekundayo OJ. The association between overactive bladder and diuretic use in the elderly. Curr Urol Rep. 2009;10(6):434–40.
Diokno AC, Brown MB, et al. Relationship between use of diuretics and continence status in the elderly. Urology. 1991;38(1):39–42.
Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults:AUA/SUFU guideline amendment 2019. J Urol. 2019;202(3):558–63.
De Wachter S, Wyndaele JJ. Frequency-volume charts: a tool to evaluate bladder sensation. Neurourol Urodyn. 2003;22:683–4.
Homma Y, et al. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology. 2011;77(60):558–63.
Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11:563–74.
Villacampa F, Ruiz MA, et al. Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness Tool. Int Urogynecol J. 2013;24:573–81.
Coyne KS, Margolis MK, Bavendam T, et al. Validation of a 3-item OAB mawareness tool. Int J Clin Pract. 2011;65:219–24.
Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome–overactive bladder symptom score. Urology. 2006;68:318–23.
Kubota Y, Kojima Y, Shibata Y, et al. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug. Neurourol Urodyn. 2011;30:1309–14.
Jackson S, Donovan J, Brookes S, et al. The Bristol Female Lower Urinary Tract Symptoms Questionnaire: development and psychometric testing. Br J Urol. 1996;77:805–12.
Homma Y, Yoshida M, Yamanishi T, et al. Core Lower Urinary Tract Symptom Score (CLSS) questionnaire: a reliable tool in the overall assessment of lower urinary tract symptoms. Int J Urol. 2008;15:816–20.
Tanaka H, Matsuda M, Moriya K, et al. Ultrasonographic measurement of bladder wall thickness as a risk factor for upper urinary tract deterioration in children with myelodysplasia. J Urol. 2008;180:312–6.
Oelke M, Hofner K, Jonas U, et al. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol. 2007;52:827–34.
Panayi DC, Tekkis P, et al. Ultrasound measurement of bladder wall thickness is associated with the overactive bladder syndrome. Neurourol Urodyn. 2010;29:1295–8.
Padilha JF, da Silva JB. Intra- and inter-rater reliability of post-void residual bladder volume with ultrasound. Int Urogynecol J. 2019;31:973–9.
Sakakibara R, Yamamoto T, Uchiyama T, Liu Z, Ito T, Yamazaki M, Awa Y, Yamanishi T, Hattori T. Is lumbar spondylosis a cause of urinary retention in elderly women? J Neurol. 2005;252(8):953–7.
Chung KL, Chao NS, Liu CS, Tang PM, Liu KK, Leung MW. Abnormal voiding parameters in children with severe idiopathic constipation. Pediatr Surg Int. 2014;30(7):747–9.
Chang SJ, Yang SS. Variability, related factors and normal reference value of post-void residual urine in healthy kindergarteners. J Urol. 2009;182(4 Suppl):1933–8.
Chang SJ, Chiang IN, Hsieh CH, Lin CD, Yang SS. Age- and gender-specific nomograms for single and dual post-void residual urine in healthy children. Neurourol Urodyn. 2013;32(7):1014–8.
Alagiakrishnan K, Valpreda M. Ultrasound bladder scanner presents falsely elevated postvoid residual volumes. Can Fam Physician. 2009;55(2):163–4.
Kolman C, Girman CJ, Jacobsen SJ, Lieber MM. Distribution of post-void residual urine volume in randomly selected men. J Urol. 1999;161(1):122–7.
Shimoni Z, Fruger E, Froom P. Measurement of post-void residual bladder volumes in hospitalized older adults. Am J Med. 2015;128(1):77–81.
Domen PM, Hofman PA, van Santbrink H, Weber WE. Predictive value of clinical characteristics in patients with suspected cauda equina syndrome. Eur J Neurol. 2009;16(3):416–9.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–78.
Malone-Lee J, Henshaw DJ, Cummings K. Urodynamic verification of an overactive bladder is not a prerequisite for antimuscarinic treatment response. BJU Int. 2003;92:415–7.
Van Brummen HJ, Heintz AP, van der Vaart CH. The association between overactive bladder symptoms and objective parameters from bladder diary and filling cystometry. Neurourol Urodyn. 2004;23:38–42.
Al-Ghazo MA, Ghalayini IF, et al. Urodynamic detrusor overactivity in patients with overactive bladder symptoms. Int Neurourol J. 2011;15:48–54.
Ho CH, Tai HC, Yu HJ. Urodynamic findings in female diabetic patients with and without overactive bladder symptoms. Neurourol Urodyn. 2010;29:424–7.
Heslington K, Hilton P. Ambulatory monitoring and conventional cystometry in asymptomatic female volunteers. Br J Obstet Gynaecol. 1996;103:434–41.
Giarenis I, Zacchè M. Is there any association between urodynamic variables and severity of overactive bladder in women with idiopathic detrusor overactivity? Neurourol Urodyn. 2017;36(3):780–3.
Guralnick ML, Grimsby G, et al. Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity. Int Urogynecol J. 2010;21:325–9.
Flisser AJ, Blaivas JG. Role of cystometry in evaluating patients with overactive bladder. Urology. 2002;60(5 Suppl 1):33–42.
Verdejo C, Salinas J, et al. “Overactive bladder”: main urinary symptoms and urodynamic patterns in the elderly. Int Urol Nephrol. 2007; https://doi.org/10.1007/s11255-004-4652-1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Costantini, E., Illiano, E. (2021). Diagnosis of Overactive Bladder. In: Balzarro, M., Li Marzi, V. (eds) Non-Neurogenic Bladder Dysfunctions. Urodynamics, Neurourology and Pelvic Floor Dysfunctions. Springer, Cham. https://doi.org/10.1007/978-3-030-57393-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-57393-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57392-8
Online ISBN: 978-3-030-57393-5
eBook Packages: MedicineMedicine (R0)